Category: Channels

Medical Properties Trust cuts Steward from portfolio, hits $801M net loss in Q3

Birmingham, Ala.-based Medical Properties Trust, one of the world’s largest hospital real estate owners posted a net loss of $801 million in the third quarter of 2024 ended Sept. 30, a 786% decrease from a $117 million gain during the same period in 20…

Tufts Medicine's CEO eyes risk-based care to boost physician job satisfaction

Embracing risk-based care models could ultimately lead to better physician job satisfaction by creating stronger incentives for health systems to free them from low-value administrative tasks, according to Tufts Medicine CEO Michael Dandorph. 

General Catalyst to acquire Summa Health for $485M

Akron, Ohio-based Summa Health has reached a $485 million definitive agreement to join Health Assurance Transformation Corp., according to a Nov. 7 news release. 

Private equity in gastroenterology: 5 things to know

Here are five key notes on the influence of private equity in gastroenterology:

GLP-1 saved heart failure patients more than $7K in medical costs

Semaglutide treatment was found to reduce healthcare costs significantly for patients with overweight or obesity and who had either heart failure or atherosclerotic cardiovascular disease, according to studies presented Nov. 3-6 at the Obesity Society’…

Bad news for gastroenterology reimbursements

Here are five reimbursement issues currently impacting gastroenterology:

Massachusetts anesthesia practice to close

Springfield (Mass.) Anesthesia Service will shutter Dec. 31, laying off 91 employees, according to a WARN notice filed with the state. 

340B spending restrictions on track for passage in California

California vote tabulations are currently backing a state ballot measure that would impose new restrictions on health systems’ 340B drug spending. 

CHIME, KLAS name top 2 health systems for EHR, digital experience

Two health systems have received the inaugural Synergy Award from the College of Healthcare Information Management Executives and KLAS Research for EHR user experience and digital health innovation.

Compounded Ozempic tied to deaths, hospitalizations: Novo Nordisk CEO

Novo Nordisk’s CEO told CNN he is “alarmed” by the risks compounded versions of semaglutide — the active ingredient in the company’s diabetes drug Ozempic and weight loss drug Wegovy — are posing to users.